Roche - Avastin (bevacizumab)
EU rules Avastin can be reimbursed for off-label use
France wants Avastin used in place of Lucentis - PMLiVE
Avastin now available in UK for ovarian cancer | Pharmafile
Avastin approval for breast cancer pulled | CBC News
Avastin - FDA prescribing information, side effects and uses
Immunotherapy Regimen Approved for Hepatocellular Carcinoma - MPR
FDA Begins Process to Remove Breast Cancer Indication from Avastin Label - rgVision Magazine
Avastin Lawsuits - Off-Label Use, Eye Infection, Blindness Risk
SecuringIndustry.com - WHO warns of fake cancer drugs in Uganda
Fake version cancer drug Avastin found in U.S. - New York Daily News
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open- label, phase 3 trial - The Lancet
PDF) Bevacizumab: Off-label use in ophthalmology
More Medicare Musings: Why Lucentis is Worth the Price Tag - Eyedolatry
Avastin, Lucentis & Zaltrap, Eylea - ppt download
EFPIA Files Complaint Against French Law Promoting Off-Label Avastin Use – Policy & Medicine
Legal threat to NHS for using cheap drug Avastin | News | The Times
Off‐label drug use – price analysis for Avastin® in ophthalmology | Emerald Insight
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial - The Lancet Oncology
ABPI chief exec backs Novartis legal challenge to off-label Avastin - PMLiVE
10. Avastin | FiercePharma
File:Bevacizumab label 01.jpg - wikidoc
Genentech: Statements | Genentech Statement on Counterfeit Drug Labeled as Avastin® (Bevacizumab) in the United States
AVASTIN(R) Vials (400 mg)
U.K. regulator supports off-label use of Avastin for serious eye condition
